Kruppel-like factor 6 (KLF6) belongs to a large family of mammalian Sp1-like/KLF transcription factors that play critical roles in regulating key cellular functions ranging from differentiation to proliferation and apoptosis. KLF6 is an evolutionarily conserved and ubiquitously expressed protein that was originally identified as an activator of pregnancy specific genes. Initial evidence has implicated KLF6 as a tumor suppressor gene, which was found to be the subject of frequent somatic mutations in certain carcinomas. Given its potential role as a tumor suppressor gene, much effort has gone into determining altered KLF6 genotypes. Results have been rather controversial since a number of studies established that genetic alterations of KLF6 were infrequently observed in distinct types of human cancers (see
These data clearly demonstrated that KLF6 loss by siRNAs increased the sub-G1 apoptotic cell population, which in turn correlated directly with nuclear DNA fragmentation. In addition, controlled overexpression of KLF6 protected HeLa cells from cisplatin-induced apoptosis.